The company expects its capital expenditure for full year 2013 to be around $100 million.
The company's practice is to provide guidance on a full year basis only. This forecast reflects Mindray's current and preliminary views, which are subject to change.
"We are revising our financial guidance for 2013, primarily due to the enduring hospital purchase slowdown in China. In other geographies, we expect some countries to perform well in the emerging markets, but political and currency issues will affect other areas. For the developed markets, we are confident about our expansion in Western Europe and expect the North American business will stabilize," commented Mr. Cheng Minghe, Mindray's Co-Chief Executive Officer and Chief Strategic Officer. "Overall, we remain upbeat about the long-term prospects of Mindray. We will continue to work hard to increase our worldwide market penetration, optimize our global operations and seek promising external growth opportunities."
Conference Call InformationMindray's management will hold an earnings conference call at 8:00 AM on November 5, 2013 U.S. Eastern Time (9:00 PM on November 5, 2013 Beijing/Hong Kong Time).
Dial-in details for the earnings conference call are as follows:
International Toll Free:United States:
800-819-0121Local dial-in numbers:United States:
+852-2475-0994 China Mobile:
400-620-8038Passcode for all regions:
MindrayA replay of the conference call may be accessed by phone at the following numbers until November 20, 2013.
U.S. Toll Free:
86589814Additionally, a live and archived webcast of this conf
|SOURCE Mindray Medical International Limited|
Copyright©2012 PR Newswire.
All rights reserved